We analyzed data from HIV-infected individuals who were clinically-eligible for ART between @ and @ ( i.e. , a first reported CD@ + < @ cells/uL or AIDS-defining illness ) from @ U.S. cohorts of the North American AIDS Cohort Collaboration on Research and Design ( NA-ACCORD ) .